Magnetic resonance imaging with Gadolinium-DTPA for assessment of bladder carcinoma and its response to treatment.
AffiliationDepartment of Diagnostic Radiology, University of Manchester.
MetadataShow full item record
AbstractMagnetic Resonance Imaging (MRI) with intravenous Gadolinium-DTPA (Gd-DTPA, Magnevist, Schering-AG) was performed in 44 patients, 32 with primary bladder carcinoma and 12 with suspected recurrence after treatment. Gd-DTPA often increased diagnostic confidence in the identification and staging of tumours confined to the bladder wall and was necessary to assess depth of bladder wall invasion when T2-weighted images were suboptimal. Enhancement after Gd-DTPA enabled distinction between necrotic and viable tumour and blood clot. There was little advantage in its use for tumours infiltrating perivesical fat or with metastases to lymph nodes or bone, in the absence of a fat suppression sequence. Gd-DTPA may therefore be useful in selected patients with tumours of Stage T3a or less in whom information about depth of bladder wall invasion is inadequately shown on pre-contrast sequences. Artefacts due to variable and inhomogeneous urine signal intensity, however, often degraded post-Gd-DTPA images of the bladder. Changes in the bladder due to radiotherapy were observed on MRI 3-4 months after treatment in patients referred for routine follow-up and in some patients with suspected recurrence. Mucosal hyperintensity, thickening and abnormal signal intensity of the muscular layers of the bladder wall, with enhancement after Gd-DTPA were demonstrated. Such changes obscured small volume or superficial recurrence of tumour after radiotherapy. Abnormal enhancement was also observed in pelvic organs and soft tissues irradiated several years earlier. Enhancement after Gd-DTPA does not therefore reliably distinguish between recurrent tumour and radiotherapy change.
CitationMagnetic resonance imaging with Gadolinium-DTPA for assessment of bladder carcinoma and its response to treatment. 1993, 47 (5):302-10 Clin Radiol
- [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
- Authors: Doringer E, Joos H, Forstner R, Schmoller H
- Issue date: 1991 Apr
- [The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?].
- Authors: Sparenberg A, Hamm B, Hammerer P, Samberger V, Wolf KJ
- Issue date: 1991 Aug
- [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
- Authors: Venz S, Hosten N, Ilg J, Mäurer J, Podrabsky P, Fedel M, Ebert T, Nagel R
- Issue date: 1996 Mar
- Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model.
- Authors: Takeda K, Kawaguchi T, Shiraishi T, Kobayashi S, Hayashi N, Yanagawa M, Tochigi H, Sakuma H, Kawamura J, Nakagawa T
- Issue date: 1998 Feb
- Staging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful?
- Authors: Neuerburg JM, Bohndorf K, Sohn M, Teufl F, Günther RW
- Issue date: 1991 Sep-Oct